curcumin β glucuronide Search Results


curcumin β glucuronide  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology curcumin β glucuronide
Concentration‐time profiles of curcumin and its metabolite <t>curcumin</t> <t>glucuronide</t> following a single oral dose of curcumin SMEDDS formulation (100 mg/kg) as determined by LC‐MS/MS. Data are means ± sd (n = 3–4). Plasma concentrations for 4T1 tumor‐bearing mice (A), tumor concentrations for 4T1 tumor‐bearing mice (B), plasma concentrations for TuBo tumor‐bearing mice (C), and tumor concentrations for TuBo tumor‐bearing plasma (D).
Curcumin β Glucuronide, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/curcumin β glucuronide/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
curcumin β glucuronide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
curcumin  (Toronto Research Chemicals)
93
Toronto Research Chemicals curcumin
Concentration‐time profiles of curcumin and its metabolite <t>curcumin</t> <t>glucuronide</t> following a single oral dose of curcumin SMEDDS formulation (100 mg/kg) as determined by LC‐MS/MS. Data are means ± sd (n = 3–4). Plasma concentrations for 4T1 tumor‐bearing mice (A), tumor concentrations for 4T1 tumor‐bearing mice (B), plasma concentrations for TuBo tumor‐bearing mice (C), and tumor concentrations for TuBo tumor‐bearing plasma (D).
Curcumin, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/curcumin/product/Toronto Research Chemicals
Average 93 stars, based on 1 article reviews
curcumin - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
substrate curcumin- β - d -glucuronide  (Apollo Scientific Ltd)
90
Apollo Scientific Ltd substrate curcumin- β - d -glucuronide
Concentration‐time profiles of curcumin and its metabolite <t>curcumin</t> <t>glucuronide</t> following a single oral dose of curcumin SMEDDS formulation (100 mg/kg) as determined by LC‐MS/MS. Data are means ± sd (n = 3–4). Plasma concentrations for 4T1 tumor‐bearing mice (A), tumor concentrations for 4T1 tumor‐bearing mice (B), plasma concentrations for TuBo tumor‐bearing mice (C), and tumor concentrations for TuBo tumor‐bearing plasma (D).
Substrate Curcumin β D Glucuronide, supplied by Apollo Scientific Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/substrate curcumin- β - d -glucuronide/product/Apollo Scientific Ltd
Average 90 stars, based on 1 article reviews
substrate curcumin- β - d -glucuronide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Concentration‐time profiles of curcumin and its metabolite curcumin glucuronide following a single oral dose of curcumin SMEDDS formulation (100 mg/kg) as determined by LC‐MS/MS. Data are means ± sd (n = 3–4). Plasma concentrations for 4T1 tumor‐bearing mice (A), tumor concentrations for 4T1 tumor‐bearing mice (B), plasma concentrations for TuBo tumor‐bearing mice (C), and tumor concentrations for TuBo tumor‐bearing plasma (D).

Journal: The FASEB Journal

Article Title: Chemopreventive efficacy of oral curcumin: a prodrug hypothesis

doi: 10.1096/fj.201900166R

Figure Lengend Snippet: Concentration‐time profiles of curcumin and its metabolite curcumin glucuronide following a single oral dose of curcumin SMEDDS formulation (100 mg/kg) as determined by LC‐MS/MS. Data are means ± sd (n = 3–4). Plasma concentrations for 4T1 tumor‐bearing mice (A), tumor concentrations for 4T1 tumor‐bearing mice (B), plasma concentrations for TuBo tumor‐bearing mice (C), and tumor concentrations for TuBo tumor‐bearing plasma (D).

Article Snippet: Curcumin β‐glucuronide was purchased from Santa Cruz Biotechnology (Dallas, TX, USA).

Techniques: Concentration Assay, Formulation, Liquid Chromatography with Mass Spectroscopy, Clinical Proteomics

Concentration‐time profiles of curcumin and its metabolite curcumin glucuronide following a single intravenous dose of curcumin glucuronide (2 mg/kg) as determined by LC‐MS. Data are means ± sd (n = 3–4/group/time point). Plasma concentrations for 4T1 tumor‐bearing mice (A), tumor concentrations for 4T1 tumor‐bearing mice (B), plasma concentrations for TuBo tumor‐bearing mice (C), and tumor concentrations for TuBo tumor‐bearing plasma (D).

Journal: The FASEB Journal

Article Title: Chemopreventive efficacy of oral curcumin: a prodrug hypothesis

doi: 10.1096/fj.201900166R

Figure Lengend Snippet: Concentration‐time profiles of curcumin and its metabolite curcumin glucuronide following a single intravenous dose of curcumin glucuronide (2 mg/kg) as determined by LC‐MS. Data are means ± sd (n = 3–4/group/time point). Plasma concentrations for 4T1 tumor‐bearing mice (A), tumor concentrations for 4T1 tumor‐bearing mice (B), plasma concentrations for TuBo tumor‐bearing mice (C), and tumor concentrations for TuBo tumor‐bearing plasma (D).

Article Snippet: Curcumin β‐glucuronide was purchased from Santa Cruz Biotechnology (Dallas, TX, USA).

Techniques: Concentration Assay, Liquid Chromatography with Mass Spectroscopy, Clinical Proteomics

Mice bearing orthotopic 4T1 tumors received either a single dose or multiple doses of curcumin SMEDDS formulation daily at 100 mg/kg for 14 d prior to tissue and plasma collection. Data shown are means ± sd (n = 4–5). A) Accumulation of curcumin in the tumor tissue after single and multiple oral doses of curcumin. *P < 0.05 compared with curcumin concentrations after 1 single dose. B) Curcumin concentrations in plasma, tumors, and livers of healthy Balb/c mice and mice bearing orthotopic 4T1 tumors. ***P< 0.001 compared with curcumin concentrations in healthy mammary tissue. C) Curcumin glucuronide concentrations in plasma, tumors, and livers of healthy Balb/c mice and mice bearing orthotopic 4T1 tumors. Plasma concentrations are provided in ng/ml. All tissue concentrations are in ng/g. Conc., concentration. **P< 0.01 compared with liver concentrations in healthy animals.

Journal: The FASEB Journal

Article Title: Chemopreventive efficacy of oral curcumin: a prodrug hypothesis

doi: 10.1096/fj.201900166R

Figure Lengend Snippet: Mice bearing orthotopic 4T1 tumors received either a single dose or multiple doses of curcumin SMEDDS formulation daily at 100 mg/kg for 14 d prior to tissue and plasma collection. Data shown are means ± sd (n = 4–5). A) Accumulation of curcumin in the tumor tissue after single and multiple oral doses of curcumin. *P < 0.05 compared with curcumin concentrations after 1 single dose. B) Curcumin concentrations in plasma, tumors, and livers of healthy Balb/c mice and mice bearing orthotopic 4T1 tumors. ***P< 0.001 compared with curcumin concentrations in healthy mammary tissue. C) Curcumin glucuronide concentrations in plasma, tumors, and livers of healthy Balb/c mice and mice bearing orthotopic 4T1 tumors. Plasma concentrations are provided in ng/ml. All tissue concentrations are in ng/g. Conc., concentration. **P< 0.01 compared with liver concentrations in healthy animals.

Article Snippet: Curcumin β‐glucuronide was purchased from Santa Cruz Biotechnology (Dallas, TX, USA).

Techniques: Formulation, Clinical Proteomics, Concentration Assay